On October 20, 2025, DLA Piper held a bootcamp for pre-IPO and growth-stage companies in the biotech and medtech industries in the firm’s New York office. Attended by nearly 100 individuals, the bootcamp covered topics including late-stage financings, paths for going public, financial preparedness, regulatory considerations, compliance issues, intellectual property
Continue Reading DLA Piper hosts bootcamp for biotech and medtech companies


